172 related articles for article (PubMed ID: 34486381)
1. Atrial fibrillation management during septal myectomy for hypertrophic cardiomyopathy: A systematic review.
Seco M; Lau JC; Medi C; Bannon PG
Asian Cardiovasc Thorac Ann; 2022 Jan; 30(1):98-107. PubMed ID: 34486381
[TBL] [Abstract][Full Text] [Related]
2. Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy?
Cui H; Schaff HV; Dearani JA; Lahr BD; Viehman JK; Geske JB; Nishimura RA; Ommen SR
J Thorac Cardiovasc Surg; 2021 Mar; 161(3):997-1006.e3. PubMed ID: 32977972
[TBL] [Abstract][Full Text] [Related]
3. Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy.
Bogachev-Prokophiev AV; Afanasyev AV; Zheleznev SI; Pivkin AN; Fomenko MS; Sharifulin RM; Karaskov AM
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1536-1542.e2. PubMed ID: 28947201
[TBL] [Abstract][Full Text] [Related]
4. Concomitant Cox-Maze IV and Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy.
Bakir NH; MacGregor RM; Khiabani AJ; Musharbash FN; Schill MR; Sinn LA; Schuessler RB; Melby SJ; Gleva MJ; Damiano RJ
Ann Thorac Surg; 2022 Jan; 113(1):109-117. PubMed ID: 33662312
[TBL] [Abstract][Full Text] [Related]
5. Surgical ablation of atrial fibrillation in hypertrophic obstructive cardiomyopathy: Outcomes of a tailored surgical approach.
Hodges K; Tang A; Rivas CG; Umana-Pizano J; Chemtob R; Desai MY; Gillinov AM; Smedira N; Wierup P
J Card Surg; 2020 Nov; 35(11):2957-2964. PubMed ID: 33111447
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.
Boll G; Rowin EJ; Maron BJ; Wang W; Rastegar H; Maron MS
Am J Cardiol; 2020 Jan; 125(1):120-126. PubMed ID: 31727261
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of concomitant surgical ablation in patients undergoing surgical myectomy for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
Kharbanda RK; Ramdat Misier NL; Van den Eynde J; El Mathari S; Tomšič A; Palmen M; Klautz RJM
Int J Cardiol; 2023 Sep; 387():131099. PubMed ID: 37263356
[TBL] [Abstract][Full Text] [Related]
8. Clinical Efficacy and Safety of Cox-Maze IV Procedure for Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy.
Meng Y; Zhang Y; Liu P; Zhu C; Lu T; Hu E; Yang Q; Nie C; Wang S
Front Cardiovasc Med; 2021; 8():720950. PubMed ID: 34409083
[No Abstract] [Full Text] [Related]
9. Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy.
Bassiouny M; Lindsay BD; Lever H; Saliba W; Klein A; Banna M; Abraham J; Shao M; Rickard J; Kanj M; Tchou P; Dresing T; Baranowski B; Bhargava M; Callahan T; Tarakji K; Cantillon D; Hussein A; Marc Gillinov A; Smedira NG; Wazni O
Heart Rhythm; 2015 Jul; 12(7):1438-47. PubMed ID: 25814420
[TBL] [Abstract][Full Text] [Related]
10. Mid-term outcomes of concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery for hypertrophic cardiomyopathy†.
Lapenna E; Pozzoli A; De Bonis M; La Canna G; Nisi T; Nascimbene S; Vicentini L; Di Sanzo S; Del Forno B; Schiavi D; Alfieri O
Eur J Cardiothorac Surg; 2017 Jun; 51(6):1112-1118. PubMed ID: 28329110
[TBL] [Abstract][Full Text] [Related]
11. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
[TBL] [Abstract][Full Text] [Related]
12. Plasma big endothelin-1 predicts new-onset atrial fibrillation after surgical septal myectomy in patients with hypertrophic cardiomyopathy.
Song C; Wang S; Guo Y; Zheng X; Lu J; Fang X; Wang S; Huang X
BMC Cardiovasc Disord; 2019 May; 19(1):122. PubMed ID: 31117937
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Long-term Success After Concomitant Surgical Ablation for Atrial Fibrillation.
Pecha S; Ghandili S; Hakmi S; Willems S; Reichenspurner H; Wagner FM
Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):294-298. PubMed ID: 28964598
[TBL] [Abstract][Full Text] [Related]
14. Effect of substrate modification in catheter ablation of paroxysmal atrial fibrillation: pulmonary vein isolation alone or with complex fractionated electrogram ablation.
Nam GB; Jin ES; Choi H; Song HG; Kim SH; Kim KH; Hwang ES; Park KM; Kim J; Rhee KS; Choi KJ; Kim YH
Tex Heart Inst J; 2012; 39(3):372-9. PubMed ID: 22719147
[TBL] [Abstract][Full Text] [Related]
15. Relationship between electrical gaps after Maze procedure and atrial tachyarrhythmias and ablation outcomes after cardiac surgery and concomitant Maze procedure.
Suzuki K; Miyamoto K; Ueda N; Nakajima K; Kamakura T; Wada M; Yamagata K; Ishibashi K; Inoue Y; Noda T; Nagase S; Aiba T; Yambe T; Kakuta T; Tadokoro N; Fukushima S; Fujita T; Kusano K
Heart Vessels; 2021 May; 36(5):675-685. PubMed ID: 33580804
[TBL] [Abstract][Full Text] [Related]
16. Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long-Term Outcome.
Dinshaw L; Münkler P; Schäffer B; Klatt N; Jungen C; Dickow J; Tamenang A; Schleberger R; Pecha S; Pinnschmidt H; Patten M; Reichenspurner H; Willems S; Meyer C
J Am Heart Assoc; 2021 Feb; 10(3):e017451. PubMed ID: 33455428
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the stand-alone Cox-Maze IV procedure in patients with longstanding persistent atrial fibrillation.
McGilvray MMO; Bakir NH; Kelly MO; Perez SC; Sinn LA; Schuessler RB; Zemlin CW; Maniar HS; Melby SJ; Damiano RJ
J Cardiovasc Electrophysiol; 2021 Oct; 32(10):2884-2894. PubMed ID: 34041815
[TBL] [Abstract][Full Text] [Related]
18. Single-Centre Experience of Surgical Myectomy for Hypertrophic Obstructive Cardiomyopathy.
Afanasyev AV; Bogachev-Prokophiev AV; Ovcharov MA; Pivkin AN; Zalesov AS; Budagaev SA; Sharifulin RM; Zheleznev SI; Karaskov AM
Heart Lung Circ; 2020 Jun; 29(6):949-955. PubMed ID: 31427226
[TBL] [Abstract][Full Text] [Related]
19. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
[TBL] [Abstract][Full Text] [Related]
20. Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: long-term outcomes and mechanisms of arrhythmia recurrence.
Santangeli P; Di Biase L; Themistoclakis S; Raviele A; Schweikert RA; Lakkireddy D; Mohanty P; Bai R; Mohanty S; Pump A; Beheiry S; Hongo R; Sanchez JE; Gallinghouse GJ; Horton R; Dello Russo A; Casella M; Fassini G; Elayi CS; Burkhardt JD; Tondo C; Natale A
Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1089-94. PubMed ID: 24114776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
